Skip to main content

Neuren Pharmaceuticals Ltd (NEU.AU) Share Price and Company Information, 2024

Neuren Pharmaceuticals Ltd

NEU.AU

Exchange: AU
Currency Australian Dollar
Open Figi: BBG000CS0G08
ISIN: NZNEUE0001S8
Primary Ticker: NEU.AU
Fiscal Year End: December
IPO Date: 2005-02-03
International Domestic: International
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Pharmaceuticals
Gic Sub Industry: Pharmaceuticals
Description: Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome. The company develops NNZ-2591, which has completed Phase I clinical trial for the treatment of Phelan-Mc Dermid, Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares. The company was incorporated in 2001 and is based in Camberwell, Australia.
Address: 697 Burke Road, Camberwell, VIC, Australia, 3124
Website: https://www.neurenpharma.com
Updated On: 2024-04-02

Highlights

Market Capitalization: 2790836480
Market Capitalization Mln: 2790.83
EBITDA: 199262000
PE Ratio: 17.92
Wall Street Target Price: 26.74
Book Value: 1.61
Earnings Share: 1.2
EPS Estimate Current Year: 0.73
EPS Estimate Next Year: 0.75
Most Recent Quarter: 2023-12-31
Profit Margin: 0.67
Operating Margin TTM: 0.89
Return On Assets TTM: 0.85
Return On Equity TTM: 1.27
Revenue TTM: 231942000
Revenue Per Share TTM: 1.82
Quarterly Revenue Growth YOY: 9.96
Gross Profit TTM: 2705000
Diluted Eps TTM: 1.2
Quarterly Earnings Growth YOY: 14.24

Valuation

Trailing PE: 17.92
Forward PE: 37.73
Price Sales TTM: 11.41
Price Book MRQ: 12.89
Enterprise Value: 2418272790
Enterprise Value Revenue: 10.42
Enterprise Value Ebitda: 12.13

Technicals

Beta: 1.98
52 Week High: 25.95
52 Week Low: 10.02
50 Day MA: 21.37
200 Day MA: 16.23

Splits & Dividends

Last Split Factor: 1:20
Last Split Date: 2017-11-21

Earnings

Report Date: 2025-01-29
Date: 2024-12-31
Before After Market: After Market
Currency: AUD
Report Date: 2024-07-29
Date: 2024-06-30
Before After Market: After Market
Currency: AUD
Report Date: 2023-02-24
Date: 2022-12-31
Before After Market: Before Market
Currency: AUD
Eps Actual: 0.06
Eps Estimate: 0.31
Eps Difference: -0.25
Surprise Percent: -80.64
Report Date: 2022-08-23
Date: 2022-06-30
Before After Market: After Market
Currency: AUD
Eps Actual: -0.06
Eps Estimate: 0.4
Eps Difference: -0.46
Surprise Percent: -11
Report Date: 2022-02-22
Date: 2021-12-31
Currency: AUD
Report Date: 2021-08-23
Date: 2021-06-30
Currency: AUD
Eps Actual: -0.07
Report Date: 2021-02-24
Date: 2020-12-31
Currency: AUD
Eps Actual: -0.04
Eps Difference: -0.04
Report Date: 2020-08-25
Date: 2020-06-30
Currency: AUD
Eps Actual: -0.05
Eps Difference: -0.05
Report Date: 2020-02-25
Date: 2019-12-31
Currency: AUD
Eps Actual: -0.03
Eps Difference: -0.03
Report Date: 2019-08-27
Date: 2019-06-30
Currency: AUD
Eps Actual: -0.08
Eps Difference: -0.08
Report Date: 2019-02-27
Date: 2018-12-31
Currency: AUD
Eps Actual: 0.07
Eps Difference: 0.07
Report Date: 2018-08-30
Date: 2018-06-30
Currency: AUD
Eps Actual: -0.04
Eps Difference: -0.04
Report Date: 2018-03-29
Date: 2017-12-31
Currency: AUD
Eps Actual: 0.07
Eps Difference: 0.07
Report Date: 2017-08-24
Date: 2017-06-30
Currency: AUD
Eps Actual: -0.04
Eps Difference: -0.04
Report Date: 2017-03-30
Date: 2016-12-31
Currency: AUD
Eps Actual: -0.06
Eps Difference: -0.06
Report Date: 2016-08-30
Date: 2016-06-30
Currency: AUD
Eps Actual: -0.08
Eps Difference: -0.08
Report Date: 2016-02-25
Date: 2015-12-31
Currency: AUD
Eps Actual: -0.1
Eps Difference: -0.1
Date: 2025-12-31
Period: +1y
Growth: 0.02
Earnings Estimate Avg: 0.75
Earnings Estimate Low: 0.32
Earnings Estimate High: 0.96
Earnings Estimate Year Ago Eps: 0.73
Earnings Estimate Number Of Analysts: 5.00
Earnings Estimate Growth: 0.02
Revenue Estimate Avg: 173500000.00
Revenue Estimate Low: 118720000.00
Revenue Estimate High: 251700000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: 0.12
Eps Trend Current: 0.75
Eps Trend7days Ago: 0.75
Eps Trend30days Ago: 0.82
Eps Trend60days Ago: 0.91
Eps Trend90days Ago: 0.91
Date: 2024-12-31
Growth: -0.39
Earnings Estimate Avg: 0.73
Earnings Estimate Low: 0.51
Earnings Estimate High: 1.13
Earnings Estimate Year Ago Eps: 1.20
Earnings Estimate Number Of Analysts: 5.00
Earnings Estimate Growth: -0.39
Revenue Estimate Avg: 153740000.00
Revenue Estimate Low: 115400000.00
Revenue Estimate High: 191700000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: -0.33
Eps Trend Current: 0.73
Eps Trend7days Ago: 0.73
Eps Trend30days Ago: 0.66
Eps Trend60days Ago: 0.55
Eps Trend90days Ago: 0.56
Eps Revisions Up Last30days: 2.00
Date: 2024-06-30
Period: +1q
Revenue Estimate Avg: 225630000.00
Revenue Estimate Low: 164700000.00
Revenue Estimate High: 290000000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: 14.50
Date: 2024-03-31
Revenue Estimate Avg: 225630000.00
Revenue Estimate Low: 164700000.00
Revenue Estimate High: 290000000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: 14.50
Date: 2023-12-31
Earnings Estimate Avg: 1.25
Earnings Estimate Low: 0.94
Earnings Estimate High: 1.55
Earnings Estimate Number Of Analysts: 5.00
Revenue Estimate Avg: 225630000.00
Revenue Estimate Low: 164700000.00
Revenue Estimate High: 290000000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: 14.50
Eps Trend Current: 1.25
Eps Trend7days Ago: 1.25
Eps Trend30days Ago: 1.30
Eps Trend60days Ago: 1.28
Eps Trend90days Ago: 1.41
Eps Revisions Down Last30days: 1.00
Date: 2023-09-30
Date: 2023-06-30
Date: 2023-03-31
Date: 2022-12-31
Growth: 0.57
Earnings Estimate Avg: -0.03
Earnings Estimate Low: -0.03
Earnings Estimate High: -0.03
Earnings Estimate Year Ago Eps: -0.07
Earnings Estimate Number Of Analysts: 2.00
Earnings Estimate Growth: 0.57
Revenue Estimate Avg: 13940000.00
Revenue Estimate Low: 13890000.00
Revenue Estimate High: 14000000.00
Revenue Estimate Number Of Analysts: 2.00
Revenue Estimate Growth: 339.00
Eps Trend Current: -0.03
Eps Trend7days Ago: -0.04
Eps Trend30days Ago: -0.04
Eps Trend60days Ago: -0.04
Eps Trend90days Ago: -0.04
Date: 2022-09-30
Date: 2022-03-31
Period: +1q
Date: 2021-12-31
Revenue Estimate Avg: 15050000.00
Revenue Estimate Low: 14000000.00
Revenue Estimate High: 16900000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: 366.07
Date: 2019-12-31
Period: +1y
Revenue Estimate Avg: 310000.00
Revenue Estimate Low: 310000.00
Revenue Estimate High: 310000.00
Revenue Estimate Number Of Analysts: 1.00
Revenue Estimate Growth: -0.96
Eps Trend7days Ago: -0.14
Eps Trend30days Ago: -0.14
Eps Trend60days Ago: -0.14
Eps Trend90days Ago: -0.14
Date: 2019-06-30
Period: +1q
Revenue Estimate Avg: 9950000.00
Revenue Estimate Low: 9950000.00
Revenue Estimate High: 9950000.00
Revenue Estimate Number Of Analysts: 1.00
Revenue Estimate Growth: 2.54
Date: 2019-03-31
Revenue Estimate Avg: 9950000.00
Revenue Estimate Low: 9950000.00
Revenue Estimate High: 9950000.00
Revenue Estimate Number Of Analysts: 1.00
Revenue Estimate Growth: 2.54
Date: 2018-12-31
Revenue Estimate Avg: 9950000.00
Revenue Estimate Low: 9950000.00
Revenue Estimate High: 9950000.00
Revenue Estimate Number Of Analysts: 1.00
Revenue Estimate Growth: 2.54
Eps Trend7days Ago: -0.03
Eps Trend30days Ago: -0.03
Eps Trend60days Ago: -0.03
Eps Trend90days Ago: -0.03
Date: 2022-12-31
Date: 2021-12-31
Eps Actual: -0.0
Date: 2020-12-31
Eps Actual: -0.0
Date: 2019-12-31
Eps Actual: -0.1
Date: 2018-12-31
Date: 2017-12-31
Date: 2016-12-31
Eps Actual: -0.1
Date: 2015-12-31
Eps Actual: -0.